BIOTORK, LLC
GAINESVILLE, FLORIDA



BioTork, LLC is a biotechnology firm based in Gainesville, Florida with roots stretching back to July 2008. Located at 5745 SW 75th St., Suite 188 in Alachua County, this trailblazer has carved out its niche by transforming economical and sustainable solutions that convert low-value materials into high-quality chemical goods. While incorporated as a Foreign Limited Liability Company (FORL) in Delaware, BioTork primarily operates out of Florida. As a leader in innovation, the company benefits from guidance by Eudes De Crecy and supports its operational integrity with Marc Penicaud serving as Secretary. BioTork is a bustling hub of about 30 employees, committed to pushing the boundaries of bioconversion technologies. The team's dedication was highlighted in October 2016 when they successfully secured funding from the Florida Institute for the Commercialization of Public Research, showcasing their forward-thinking ethos. The company makes it easy to reach out and learn more via phone at (352) 505-8611 or through their website, biotork.com. With a Fei Number of 262917843, BioTork is constantly focusing on driving advancements in sustainability and efficiency in biochemical processes, positioning itself as an innovative force in the industry.

KEY FACTS ABOUT BIOTORK, LLC

Company name
BIOTORK, LLC
Status
Inactive
Filed Number
M08000003481
FEI Number
262917843
Date of Incorporation
July 23, 2008
Home State
DE
Company Type
Foreign Limited Liability

CONTACTS

Website
https://biotork.com
Phones
(352) 505-8611

BIOTORK, LLC NEAR ME

Principal Address
6911 NW 22nd St.,
Gainesville,
FL,
32653,
US
Mailing Address
5745 SW 75TH ST. #188,
GAINESVILLE,
FL,
32608

See Also

Officers and Directors

The BIOTORK, LLC managed by the two persons from GAINESVILLE on following positions: Manager, Secr

Eudes De Crecy

Position
Manager Active
From
GAINESVILLE, FL

Marc Penicaud

Position
Secr Active
From
GAINESVILLE, FL





Registered Agent is Eudes De Crecy

From
GAINESVILLE, 32608

Events

September 26, 2025
REVOKED FOR ANNUAL REPORT

Annual Reports

2024
May 22, 2024
2023
March 25, 2023